Investing in the future of pharma

Published: 20-Apr-2017 Featured companies: GEA Pharma and Healthcare
Manufacturing

GEA is taking the pharmaceutical manufacturing industry further, faster, with a significant investment in a new, state-of-the-art Pharma Solids Center

You need to be a subscriber to read this article.
Click here to find out more.

In May this year, representing the organisation’s continued commitment and ongoing support for the current and future pharmaceutical industry, the company will officially open its recently expanded GEA Pharma Solids Center (GPSC) in Wommelgem, Belgium.

With a total footprint of 1100 m2, including 200 m2 of technical space, GEA’s multimillion Euro investment in its Wommelgem facility embodies the state-of-the-art in oral solid dosage (OSD) form testing, development and optimisation.

Now almost tripled in size, the GPSC offers a full range of process technologies (both batch and continuous) to produce pharmaceutical OSD forms.

Dr Kevin Robinson spoke to GEA’s Frans K.A. Maas, VP Pharma Solids, and Phil Gabb, Senior Sales Director, Pharma Solids, to find out more.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

Featured companies

GEA is a leading provider of process technology and packaging solutions for the pharmaceutical, biopharmaceutical, biotechnology and nutraceutical industries. Our portfolio...
See more

You may also like

Manufacturing

Continuous innovation: redefining the future of pharmaceutical manufacturing

Read more
In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Relevant companies

See more

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
Manufacturing

Almac expands bioavailability capabilities to address a critical need in drug development

Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
Manufacturing

Sustainability that performs: how GEA is building a better future for pharma

By embedding ESG principles into pharmaceutical manufacturing, GEA is delivering measurable sustainability performance without compromising compliance or productivity
Manufacturing

GEA raises guidance following strong H1 performance

Revised forecast reflects improved margins, robust order intake and efficiency gains
Manufacturing

First product chambers placed in GEA's "Factory of the Future"

Responding to the growing demand for freeze-drying systems, GEA Pharma & Healthcare is investing €80m in the construction of a pharmaceutical technology centre in Elsdorf (North Rhine-Westphalia)
Manufacturing

A forward-thinking approach to reducing downtime and costs in the pharmaceutical industry

Implementing predictive maintenance and a lifecycle package can significantly reduce both downtime and costs in the pharmaceutical industry, emphasises Benoit Dehaene from GEA Pharma & Healthcare
Manufacturing

LYONOVA: Microwave-assisted freeze drying

To overcome the bottleneck of poor heat transfer from freeze dryer shelves to the product, GEA experts have further developed the concept of microwave-assisted freeze drying and applied radio frequency technology to make the process faster, more energy efficient and less complex. The result is LYONOVA
Subscribe now